Your Location:Home >Products >Biochemical Engineering >189691-06-3
Appearance:white powder
Purity:99%
Buy High Quality Buy Reliable Quality pt141 189691-06-3 In Bulk Supply We supply high quality PT-141 (CAS 189691-06-3), in stock, factory directly supply to clients, lower prices, more competitiveness.
PT-141 is white powder, while it's Molecular Formula is C50H68N14O10. Treatment of sexual dysfunction (melanocortin receptor agonist).Bremelanotide is used to treat low sexual desire in women who have not gone through menopause and have not had low sexual desire in the past.bremelanotide should be used only to treat low sexual desire that occurs with any type of sexual activity, in any sexual situation, or with any sexual partner.Bremelanotide should not be used to treat low sexual desire that is caused by relationship problems, health problems, mental illness, or by using certain drugs or medications.https://www.drugs.com
The CAS number of PT-141 is 189691-06-3.
More information of PT-141 189691-06-3 are:
Synonyms |
N-Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine (2-7)-lactam;Bremelanotide;PT 141; |
CAS Number |
189691-06-3 |
Molecular Formula |
C50H68N14O10 |
Molecular Weight |
1025.18 |
Density |
1.43 g/cm3 |
PSA |
376.47000 |
LogP |
3.50620 |
Pka |
3.37±0.70(Predicted) |
Bremelanotide (Vyleesi?) was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. Bremelanotide activates melanocortin receptors,but the mechanism by which it improves sexual desire is unknown. To use bremelanotide, women inject it under the skin ofthe abdomen or thigh at least 45 minutes before anticipated sexual activity.The optimal time to inject bremelanotide may vary based on the duration of benefit and side effects experienced. More than one dose of bremelanotide should not be used within 24 hours or more than eight doses per month. Common side effects include nausea, vomiting, flushing, injection site reactions, and headache. Bremelanotide should not be used in women with high blood pressure that is uncontrolled or in those with known cardiovascular disease, and it is not recommended for women at high risk for cardiovascular disease. The safety and efficacy of bremelanotide has not been studied in breast cancer survivors, and there are no recommendations regarding its use in this population.
InChI:InChI=1/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41?/m0/s1
Articles related to PT-141:
公司英文名称 is a quality supplier and manufacturer of PT-141 . You can buy high quality, low price PT-141 189691-06-3 here. Contact us.
CAS:119356-77-3
CAS:868844-74-0
CAS:68521-88-0
CAS:121062-08-6